Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
GlobeNewswire, Inc.
NEPTUNE is evaluating urcosimod as a potential first-in-class treatment for neuropathic corneal pain First patients enrolled by Dr. Melissa Toyos at Toyos Clinic in Nashville, TN LONDON and NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma...
New DHN Pacific Rim Director comes home to where his Navy Medicine career began
DVIDS - Georgia
SAN DIEGO - Nearly three decades ago, Rear Adm. Reginald S. Ewing III, a native of Churchville, New York, came to Naval Medical Center San Diego (NMCSD) as a pediatric resident, learning to specialize in the care of children, from fragile newborns...
Youth dialogue on mental health and well-being in education
UNESCO
2 - 2.10 PM: Opening & welcome Kabi Paudel and Nour Aldulaimy, SDG 4 Youth & Student Network Poem on mental health by Yande Chionita Banda 2.10 - 2.20 PM : Framing Definitions and key concepts on Mental Health and Psychosocial Support Yongfeng...
Study warns AI productivity gains could erode the payroll base funding worker protection
EIN Presswire
A research calls for shifting tax systems away from payroll and toward value creation ROME, ITALY, October 6, 2026 /EINPresswire.com/ -- Artificial intelligence may raise economic output while shrinking the payroll contributions that finance...
Lancia Gallery Launches in Los Angeles, Celebrating Italian Automotive Design Through Fine-Art Photography
EIN Presswire
Created by Gordon Fraser and photographer Walter Fulbright, Lancia Gallery explores Italian automotive design through the architecture of Los Angeles.
Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal
GlobeNewswire, Inc.
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that its innovative CARTIHEAL AGILI-C Cartilage Repair Implant is now commercially available in Europe.
Angelini Ventures and EIB Co-lead $58 Million Series A Financing in Rouge Therapeutics to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
GlobeNewswire, Inc.
Marks the fourth investment completed under Angelini Ventures’ €150 million co-investment partnership with the European Investment Bank in less than 12 months Regina Hodits from Angelini Ventures to join Rouge Therapeutics’ Board of Directors...
RougeTx Launches with $58 Million Series A Financing to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
GlobeNewswire, Inc.
Series A co-led by BioGeneration Ventures, Angelini Ventures and Kurma Partners, with participation from Epidarex Capital, Vesalius Biocapital Partners, ROM Utrecht Region, p53 Invest and Kerna Ventures.
Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026
GlobeNewswire, Inc.
Data demonstrated scalable production, in vivo function and immune evasion, and updated progress toward clinical dosing of CNTY-813, Century's iPSC-derived islet replacement therapy for type 1 diabetes CNTY-813 IND submission remains on track for...
Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes
GlobeNewswire, Inc.
Company announcement – No. 52 / 2026 Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2...
Gias Foods, Inc. Recalls bettergoods Authentic Italian Lemon Alfredo Fettuccine Because of Possible Health Risk
GlobeNewswire, Inc.
NEW YORK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Gias Foods of New York, NY is recalling all lot codes of bettergoods Authentic Italian Lemon Alfredo Fettuccine, because it has the potential to be contaminated with Listeria monocytogenes, an organism...
Italfarmaco Presents New Givinostat (Duvyzat®) Clinical Data Supporting Preservation of Upper Limb Function in Duchenne Muscular Dystrophy Patients at the 2026 World Muscle Society Congress
GlobeNewswire, Inc.
New data suggest that givinostat treatment may slow the decline of upper limb function in boys with Duchenne muscular dystrophy compared with modelled external comparator disease trajectories derived from a single centre natural history study...
Influential Women Features Vita Oyler: Champions Resilience Through Chronic Pain Rehabilitation And Holistic Wellness
EIN Presswire
CALIFORNIA, CA, UNITED STATES, September 30, 2026 /EINPresswire.com/ -- A Lifelong Commitment To Helping Others Find Practical Paths Forward California – With more than 35 years of experience in rehabilitation counseling, Vita Oyler has...
Santhera Pharmaceuticals Half Year Results for the six months ending 30 June 2026
GlobeNewswire, Inc.
Ad hoc announcement pursuant to Art. 53 LR. A conference call will be held on September 30, 2026, at 14:00 CEST / 13:00 BST / 08:00 EDT. Details are at the end of this news release Strong momentum and expanding global access position AGAMREE® for...
Fire Aboard Commercial Ship Off Romania Leaves Two Crew Dead
MENAFN
(MENAFN) Two crew members died and 11 others were injured after a fire erupted aboard a commercial vessel operating in Romania’s exclusive economic zone in the Black Sea, authorities said Monday.
Global Software as a Medical Device Market to Observe Stupendous Growth at a CAGR of ~17% by 2034 | DelveInsight
GlobeNewswire, Inc.
New York, USA, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Global Software as a Medical Device Market to Observe Stupendous Growth at a CAGR of ~17% by 2034 | DelveInsight The software as a medical device market is experiencing strong growth, driven by the...
NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease
GlobeNewswire, Inc.
- SPINOZA is studying obicetrapib in adults with biomarker evidence suggestive of preclinical Alzheimer’s disease who do not have noticeable memory or functional symptoms- - The study will evaluate changes in blood-based biomarkers associated with...
VCD Medical Receives U.S. FDA 510(k) Clearance for VEnice™ Vein Closure Device
GlobeNewswire, Inc.
Brescia, Italy, Sept. 29, 2026 (GLOBE NEWSWIRE) -- VCD Medical, an Italy-based company developing novel, minimally invasive vein closure technologies, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its VEnice™ Vein...
Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business
GlobeNewswire, Inc.
ROSELAND, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a medical technology company specializing in advanced computerized injection and drug-delivery technologies, today highlighted continued progress...
4BIO Capital leads €40 Million ($45M) seed financing of Aptadir Therapeutics to advance first-in-class demethylating medicines
GlobeNewswire, Inc.
Funds will advance novel class of RNA inhibitors to reverse intractable genetic conditions Seed led by 4BIO Capital with follow-on participation from the company's original pre-seed investor EXTEND (CDP Venture Capital SGR, Angelini Ventures and...
Sign up for:
Health Watch Italy
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.